NCT06491134View on ClinicalTrials.gov

Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 27, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

February 28, 2028

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
DRUG

Liposomal Irinotecan Hydrochloride

liposomal irinotecan With Cisplatin and Concurrent Radiotherapy

All Listed Sponsors
lead

Hebei Medical University Fourth Hospital

OTHER

NCT06491134 - Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter